236 related articles for article (PubMed ID: 19527492)
1. Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas.
Nielsen M; de Miranda NF; van Puijenbroek M; Jordanova ES; Middeldorp A; van Wezel T; van Eijk R; Tops CM; Vasen HF; Hes FJ; Morreau H
BMC Cancer; 2009 Jun; 9():184. PubMed ID: 19527492
[TBL] [Abstract][Full Text] [Related]
2. Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis?
Aimé A; Coulet F; Lefevre JH; Colas C; Cervera P; Flejou JF; Lascols O; Soubrier F; Parc Y
Cancer Genet; 2015; 208(7-8):390-5. PubMed ID: 26056087
[TBL] [Abstract][Full Text] [Related]
3. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.
van Puijenbroek M; Nielsen M; Tops CM; Halfwerk H; Vasen HF; Weiss MM; van Wezel T; Hes FJ; Morreau H
Clin Cancer Res; 2008 Jan; 14(1):139-42. PubMed ID: 18172263
[TBL] [Abstract][Full Text] [Related]
4. Oxidative DNA damage drives carcinogenesis in MUTYH-associated-polyposis by specific mutations of mitochondrial and MAPK genes.
Venesio T; Balsamo A; Errichiello E; Ranzani GN; Risio M
Mod Pathol; 2013 Oct; 26(10):1371-81. PubMed ID: 23599153
[TBL] [Abstract][Full Text] [Related]
5. MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.
Morak M; Laner A; Bacher U; Keiling C; Holinski-Feder E
Clin Genet; 2010 Oct; 78(4):353-63. PubMed ID: 20618354
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
[TBL] [Abstract][Full Text] [Related]
7. Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.
Christie M; Jorissen RN; Mouradov D; Sakthianandeswaren A; Li S; Day F; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Simpson AJ; Tomlinson IP; Gibbs P; Sieber OM
Oncogene; 2013 Sep; 32(39):4675-82. PubMed ID: 23085758
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.
Grover S; Kastrinos F; Steyerberg EW; Cook EF; Dewanwala A; Burbidge LA; Wenstrup RJ; Syngal S
JAMA; 2012 Aug; 308(5):485-492. PubMed ID: 22851115
[TBL] [Abstract][Full Text] [Related]
9. A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer.
Viel A; Bruselles A; Meccia E; Fornasarig M; Quaia M; Canzonieri V; Policicchio E; Urso ED; Agostini M; Genuardi M; Lucci-Cordisco E; Venesio T; Martayan A; Diodoro MG; Sanchez-Mete L; Stigliano V; Mazzei F; Grasso F; Giuliani A; Baiocchi M; Maestro R; Giannini G; Tartaglia M; Alexandrov LB; Bignami M
EBioMedicine; 2017 Jun; 20():39-49. PubMed ID: 28551381
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
[TBL] [Abstract][Full Text] [Related]
12. Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE).
Forgó E; Gomez AJ; Steiner D; Zehnder J; Longacre TA
Histopathology; 2020 Feb; 76(3):366-374. PubMed ID: 31479159
[TBL] [Abstract][Full Text] [Related]
13. The first mutations in the MYH gene reported in Moroccan colon cancer patients.
Laarabi FZ; Cherkaoui Jaouad I; Baert-Desurmont S; Ouldim K; Ibrahimi A; Kanouni N; Frebourg T; Sefiani A
Gene; 2012 Mar; 496(1):55-8. PubMed ID: 22266422
[TBL] [Abstract][Full Text] [Related]
14. MutYH (MYH) and colorectal cancer.
Sampson JR; Jones S; Dolwani S; Cheadle JP
Biochem Soc Trans; 2005 Aug; 33(Pt 4):679-83. PubMed ID: 16042573
[TBL] [Abstract][Full Text] [Related]
15. Role of inherited defects of MYH in the development of sporadic colorectal cancer.
Kambara T; Whitehall VL; Spring KJ; Barker MA; Arnold S; Wynter CV; Matsubara N; Tanaka N; Young JP; Leggett BA; Jass JR
Genes Chromosomes Cancer; 2004 May; 40(1):1-9. PubMed ID: 15034862
[TBL] [Abstract][Full Text] [Related]
16. MUTYH hotspot mutations in unselected colonoscopy patients.
Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
[TBL] [Abstract][Full Text] [Related]
17. MUTYH-associated polyposis (MAP).
Nielsen M; Morreau H; Vasen HF; Hes FJ
Crit Rev Oncol Hematol; 2011 Jul; 79(1):1-16. PubMed ID: 20663686
[TBL] [Abstract][Full Text] [Related]
18. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.
van Puijenbroek M; Nielsen M; Reinards TH; Weiss MM; Wagner A; Hendriks YM; Vasen HF; Tops CM; Wijnen J; van Wezel T; Hes FJ; Morreau H
Fam Cancer; 2007; 6(1):43-51. PubMed ID: 17039270
[TBL] [Abstract][Full Text] [Related]
19. Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair.
Parker AR; Sieber OM; Shi C; Hua L; Takao M; Tomlinson IP; Eshleman JR
Carcinogenesis; 2005 Nov; 26(11):2010-8. PubMed ID: 15987719
[TBL] [Abstract][Full Text] [Related]
20. Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations.
Thirlwell C; Howarth KM; Segditsas S; Guerra G; Thomas HJ; Phillips RK; Talbot IC; Gorman M; Novelli MR; Sieber OM; Tomlinson IP
Br J Cancer; 2007 Jun; 96(11):1729-34. PubMed ID: 17505512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
